We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The CMA has today published its main concerns following an initial review into the veterinary sector.
Understand and avoid all types of anti-competitive and cartel activity including price-fixing, collusion, bid-ridding and sharing markets. Know how to report concerns to the CMA.
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF).
Information for people who wish to apply to release a vaccine or a blood product to market in the UK.
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
How the MHRA processes variations to Marketing Authorisations (MAs)
The CMA is investigating the anticipated acquisition by AlphaTheta Corporation of Serato Audio Research Limited.
How the MHRA assesses Marketing Authorisation Applications (MAA) for medicines referred under Article 29.
The actions to take for sourcing medicines in different circumstances.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
You must get permission to export certain drugs and medicines.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
From 13 May 2024 we are introducing a change to the procedure for new Marketing Authorisation (MA) applications, where a joint assessment of labels is requested.
If you're advertising or marketing, including direct marketing, you must be accurate and honest and follow the advertising codes of practice
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Form to apply for approval to hold an exempt cattle market, slaughter gathering or dedicated sale for TB restricted cattle in England and Wales.
Annual and quarterly headline statistics on reported and resolved market access barriers published by the Department for Business and Trade (DBT).
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
Guidance for suppliers of cloud technology, digital outcomes, user research studios and user research participants.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.